NUMA’s Acquisition of YAYS

Greenberg Traurig has advised NUMA Group on the deal. NUMA Group executed the acquisition of the online platform YAYS from Proprium Capital Partners in several countries....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Hangzhou Zhongmei Huadong Pharmaceutical Co..’s Licensing Agreement with Arcutis Biotherapeutic

Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Hangzhou Zhongmei Huadong Pharmaceutical’s Licensing Agreement with MC2 Therapeutics

Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Hangzhou Zhongmei Huadong Pharmaceutical, a subsidiary of Huadong Medicine, negotiated a licensing agreement...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here